The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)

Clinical and Experimental Immunology

Volumn 119, Issue 3, 2000, Pages 523-529

  Gasim, S ^a   Elhassan, A M ^b   Kharazmi, A ^a   Khalil, E A G ^b   Ismail, A ^a   Theander, Thor G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

IFN ; Immune reactivity; Kala azar; PKDL

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HUMAN; LEISHMANIA DONOVANI; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

EID: 0034023888     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01163.x     Document Type: Article

References (17)

1. 1 Carvallo EM, Teixeira RS, Johnoson WD. Cell mediated immunity in American visceral leishmaniasis; reversible immunosuppression during acute infection. Infect Immun 1981; 33:498-502.
2. 2 Halder JP, Chose S, Sana KC, Gnose AC. Cell-mediated immune response in Indian Kala-azar and post kala-azar dermal leishmaniasis. Infect Immun 1983; 42:702.
3. 3 Ghalib HW, Piuvezam MR, Sheiky YAW et al. Tnterleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993; 92:324-9.
4. 4 Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson Wd Jr. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985; 76:2066-9.
5. 5 Kemp M, Kurtzhals JAL, Bendtzen K et al. Leishmania donovani specific Th1 and Th2 like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993; 61:1069-73.
6. 6 Zijlstra EE, ElHassan AM, Ismail A, Ghalib HW. Endemic kala-azar in Eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1994; 51:826-36.
7. 7 Ismail A, El Hassan AM, Kemp K et al. T cell phenotypes and cytokine profile. J Pathol in press.
8. 8 ElHassan AM, Ghalib HW, Zijlstra EE et al. Post kala azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans Roy Soc Trop Med Hyg 1992; 86:245-8.
9. 9 Zijlstra EE, ElHassan AM, Ismail A. Endemic kala-azar in Eastern Sudan: post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1995; 52:299-305.
10. 10 Hviid L, Albeck G, Hansen B, Theander TG, Talbot A. A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells. J Immunol Methods 1993; 157:135-42.
11. 11 Kemp M, Theander TG, Handman E et al. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand J Tmmunol 1991; 33:219-24.
12. 12 Kurtzhals JAL, Hansen MB, Hey AS, Poulsen LK. Measurement of antigen-dependent interleukin-4 production by human peripheral blood mononuclear cells. Introduction of an amplification step using ionomycin and phorbol myristate acetate. J Immunol Methods 1992; 156:239-45.
13. 13 Gasim S, El Hassan AM, Khalil EAG et al. High levels of plasma interleukin 10 (IL10) and expression of IL10 by keratinocytes during visceral leishinaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Clin Exp Immunol 1998; 111:64-69.
14. 14 Ghalib HW, Whittle JA, Kubin M et al. IL12 enhances Th 1-type responses in human Leishmania donovani infections. J Immunol 1995; 154:4623-9.
15. 15 Ghose AC, Chowdhury AB. T-lymphocytes in kala azar and Post kala azar dermal leishmaniasis. Bull Calcutta School Trop Medicine 1977; 25:3-4.
16. 16 Nandy A, Neogy AB, Ghosh Dastidar B, Sarkar M, Mallick KK, Chowdhury AB. Immune response and drug response in kala-azar and Post kala-azar dermal leishmaniasis. In: Proceedings of the Indo-UK Workshop on Leishmaniasis. New Delhi: Indian Council of Medical Research, 1983:161-70.
17. 17 Neogy AB, Nandy A, Gosh Dastidar B, Chowdhury AB. Modulation of the cell-mediated immune response in kala-azar and post kala-azar dermal leishmaniasis in relation to chemotherapy. Annal Trop Med Parasit 1988; 82:27-34.